Neto, Tertuliano Alves Pereira
Sidney, John
Grifoni, Alba http://orcid.org/0000-0002-2209-5966
Sette, Alessandro http://orcid.org/0000-0001-7013-2250
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI168347, 75N93019C00001)
Article History
Received: 6 July 2023
Accepted: 28 August 2023
First Online: 19 September 2023
Change Date: 14 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41423-023-01099-6
Competing interests
: AS is a consultant for AstraZeneca Pharmaceuticals, Calyptus Pharmaceuticals, Inc, Darwin Health, EmerVax, EUROIMMUN, F. Hoffman-La Roche Ltd, Fortress Biotech, Gilead Sciences, Granite bio., Gritstone Oncology, Guggenheim Securities, Moderna, Pfizer, RiverVest Venture Partners, and Turnstone Biologics. AG is a consultant for Pfizer. LJI has filed for patent protection for various aspects of T-cell epitope and vaccine design work. JS and TAPN declare no conflicts of interest.